A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

It’s a synthetic version of the hormone GLP-1, which helps regulate our metabolism and hunger. Semaglutide and other newer GLP-1 medications have proven to be far more effective at treating ...

As “GLP-1 receptor agonists,” they mimic a naturally occurring hormone, GLP-1, released in the body after someone eats. For reasons that remain unclear, many patients that struggle with ...

Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...

Recently, there has been a lot of buzz around GLP-1 weight loss injections. Talk of Ozempic or Wegovy has been hard to miss.